#Review
Gastrointestinal cancer: molecular pathogenesis and targeted therapy doi.org/10.1186/s435...
#GastrointestinalTumor #Immunotherapy #TargetedTherapy #SignalTransduction
Gastrointestinal cancer: molecular pathogenesis and targeted therapy doi.org/10.1186/s435...
#GastrointestinalTumor #Immunotherapy #TargetedTherapy #SignalTransduction
Gastrointestinal cancer: molecular pathogenesis and targeted therapy - Molecular Biomedicine
Gastrointestinal (GI) cancers pose a significant global health burden, driven by complex molecular alterations and microenvironmental interactions. Advances in molecular pathogenesis have elucidated r...
doi.org
December 19, 2025 at 5:37 AM
#Review
Gastrointestinal cancer: molecular pathogenesis and targeted therapy doi.org/10.1186/s435...
#GastrointestinalTumor #Immunotherapy #TargetedTherapy #SignalTransduction
Gastrointestinal cancer: molecular pathogenesis and targeted therapy doi.org/10.1186/s435...
#GastrointestinalTumor #Immunotherapy #TargetedTherapy #SignalTransduction
🧬Molecule of the Moment | Another major breakthrough: #CDH17-targeting #ADC #7MW491 that conjugates Topi MF-6 via a cleavable linker, specifically designed to tackle the #MDR challenge in #GI tumors.
#TopiMF-6 #GastrointestinalTumor #Cytotoxicity #HighSpecificity
#TopiMF-6 #GastrointestinalTumor #Cytotoxicity #HighSpecificity
November 18, 2025 at 8:02 PM
🧬Molecule of the Moment | Another major breakthrough: #CDH17-targeting #ADC #7MW491 that conjugates Topi MF-6 via a cleavable linker, specifically designed to tackle the #MDR challenge in #GI tumors.
#TopiMF-6 #GastrointestinalTumor #Cytotoxicity #HighSpecificity
#TopiMF-6 #GastrointestinalTumor #Cytotoxicity #HighSpecificity